859 related articles for article (PubMed ID: 18388160)
1. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
[TBL] [Abstract][Full Text] [Related]
2. Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
Hetland ML; Stengaard-Pedersen K; Junker P; Østergaard M; Ejbjerg BJ; Jacobsen S; Lottenburger T; Hansen I; Tarp U; Andersen LS; Svendsen A; Pedersen JK; Lauridsen UB; Ellingsen T; Lindegaard H; Pødenphant J; Vestergaard A; Jurik AG; Hørslev-Petersen K;
Ann Rheum Dis; 2010 Oct; 69(10):1789-95. PubMed ID: 20444751
[TBL] [Abstract][Full Text] [Related]
3. Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years' functional and radiographic outcome in early rheumatoid arthritis.
Hetland ML; Østergaard M; Stengaard-Pedersen K; Junker P; Ejbjerg B; Jacobsen S; Ellingsen T; Lindegaard H; Pødenphant J; Vestergaard A; Jurik AG; Krogh NS; Hørslev-Petersen K;
Scand J Rheumatol; 2019 Jan; 48(1):1-8. PubMed ID: 30101636
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI.
Gandjbakhch F; Foltz V; Mallet A; Bourgeois P; Fautrel B
Ann Rheum Dis; 2011 Dec; 70(12):2159-62. PubMed ID: 21859693
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression.
Haavardsholm EA; Bøyesen P; Østergaard M; Schildvold A; Kvien TK
Ann Rheum Dis; 2008 Jun; 67(6):794-800. PubMed ID: 17981915
[TBL] [Abstract][Full Text] [Related]
6. Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial.
Baker JF; Ostergaard M; Emery P; Hsia EC; Lu J; Baker DG; Conaghan PG
Ann Rheum Dis; 2014 Nov; 73(11):1968-74. PubMed ID: 23904470
[TBL] [Abstract][Full Text] [Related]
7. MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression.
Bøyesen P; Haavardsholm EA; Ostergaard M; van der Heijde D; Sesseng S; Kvien TK
Ann Rheum Dis; 2011 Mar; 70(3):428-33. PubMed ID: 20810395
[TBL] [Abstract][Full Text] [Related]
8. MRI-detected subclinical joint inflammation is associated with radiographic progression.
Krabben A; Stomp W; van Nies JA; Huizinga TW; van der Heijde D; Bloem JL; Reijnierse M; van der Helm-van Mil AH
Ann Rheum Dis; 2014 Nov; 73(11):2034-7. PubMed ID: 25074691
[TBL] [Abstract][Full Text] [Related]
9. The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints: a comparison of the OMERACT rheumatoid arthritis magnetic resonance imaging score applied to different joint combinations and the Sharp/van der Heijde radiographic score.
Ejbjerg BJ; Vestergaard A; Jacobsen S; Thomsen HS; Østergaard M
Arthritis Rheum; 2005 Aug; 52(8):2300-6. PubMed ID: 16052593
[TBL] [Abstract][Full Text] [Related]
10. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.
Forslind K; Svensson B
Scand J Rheumatol; 2016; 45(2):99-102. PubMed ID: 26313244
[TBL] [Abstract][Full Text] [Related]
11. Early prediction of rheumatoid arthritis by magnetic resonance imaging in the absence of anti-cyclic citrullinated peptide antibodies and radiographic erosions in undifferentiated inflammatory arthritis patients: a prospective study.
Ji L; Li G; Xu Y; Zhou W; Zhang Z
Int J Rheum Dis; 2015 Nov; 18(8):859-65. PubMed ID: 25483781
[TBL] [Abstract][Full Text] [Related]
12. Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study.
Palosaari K; Vuotila J; Takalo R; Jartti A; Niemelä RK; Karjalainen A; Haapea M; Soini I; Tervonen O; Hakala M
Rheumatology (Oxford); 2006 Dec; 45(12):1542-8. PubMed ID: 16670155
[TBL] [Abstract][Full Text] [Related]
13. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
[TBL] [Abstract][Full Text] [Related]
14. Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage.
Haavardsholm EA; Østergaard M; Hammer HB; Bøyesen P; Boonen A; van der Heijde D; Kvien TK
Ann Rheum Dis; 2009 Oct; 68(10):1572-9. PubMed ID: 19019893
[TBL] [Abstract][Full Text] [Related]
15. Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up study.
Lindegaard HM; Vallø J; Hørslev-Petersen K; Junker P; Østergaard M
Ann Rheum Dis; 2006 Sep; 65(9):1208-12. PubMed ID: 16540550
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: a study of patients receiving combined anakinra and methotrexate treatment.
Østergaard M; Duer A; Nielsen H; Johansen JS; Narvestad E; Ejbjerg BJ; Baslund B; Møller JM; Thomsen HS; Petersen J
Ann Rheum Dis; 2005 Oct; 64(10):1503-6. PubMed ID: 15778238
[TBL] [Abstract][Full Text] [Related]
17. The OMERACT-RAMRIS rheumatoid arthritis magnetic resonance imaging joint space narrowing score: intrareader and interreader reliability and agreement with computed tomography and conventional radiography.
Døhn UM; Conaghan PG; Eshed I; Boonen A; Boyesen P; Peterfy CG; Lillegraven S; Ejbjerg B; Gandjbakhch F; Bird P; Foltz V; Genant HK; Haavardsholm E; McQueen FM; Østergaard M
J Rheumatol; 2014 Feb; 41(2):392-7. PubMed ID: 24293568
[TBL] [Abstract][Full Text] [Related]
18. Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques.
Conaghan PG; Østergaard M; Bowes MA; Wu C; Fuerst T; van der Heijde D; Irazoque-Palazuelos F; Soto-Raices O; Hrycaj P; Xie Z; Zhang R; Wyman BT; Bradley JD; Soma K; Wilkinson B
Ann Rheum Dis; 2016 Jun; 75(6):1024-33. PubMed ID: 27002108
[TBL] [Abstract][Full Text] [Related]
19. Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients.
Østergaard M; Emery P; Conaghan PG; Fleischmann R; Hsia EC; Xu W; Rahman MU
Arthritis Rheum; 2011 Dec; 63(12):3712-22. PubMed ID: 22127693
[TBL] [Abstract][Full Text] [Related]
20. Effect of very early treatment in rheumatoid arthritis on bone oedema and synovitis, using magnetic resonance imaging.
Kosta PE; Voulgari PV; Zikou AK; Tsampoulas K; Drosos AA; Argyropoulou MI
Scand J Rheumatol; 2012 Oct; 41(5):339-44. PubMed ID: 22646866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
